| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3K | -61.8% | -56.6% |
| R&D Expense | $189K | +15.9% | +3503.0% |
| SG&A Expense | $1.7M | +1.7% | +21.1% |
| Operating Income | -$1.7M | -2.0% | -21.5% |
| Interest Expense | $3K | -33.3% | -19.4% |
| Pre-tax Income | -$1.7M | -1.9% | -21.4% |
| Net Income | -$1.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $0 | — | — |
| Accounts Receivable | $11K | -13.2% | -20.4% |
| Current Assets | $6.9M | -20.4% | +163.7% |
| Total Assets | $8.8M | -15.5% | +96.1% |
| Current Liabilities | $398K | +7.8% | +29.1% |
| Total Liabilities | $637K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | — | — |
| Capital Expenditures | $187K | — | — |
| Investing Cash Flow | -$341K | — | — |
| Financing Cash Flow | $3.2M | — | — |
| Free Cash Flow | -$4.6M | — | — |
| -1.9% |
| -21.4% |
| EPS (Basic) | -$0.98 | -1.0% | -1533.3% |
| EPS (Diluted) | -$0.98 | -1.0% | -1533.3% |
| -5.1% |
| -19.9% |
| Stockholders' Equity | $8.2M | -16.2% | +121.1% |